These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16344673)

  • 1. Multifocal Castleman disease in pediatrics: case report.
    Baserga M; Rosin M; Schoen M; Young G
    J Pediatr Hematol Oncol; 2005 Dec; 27(12):666-9. PubMed ID: 16344673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Herpesvirus Type 8-positive Multicentric Castleman Disease.
    Melikyan AL; Egorova EK; Julhakyan HL; Kovrigina AL; Savchenko VG
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S159-65. PubMed ID: 27133959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentric Castleman's disease in a renal allograft recipient: a case report and literature review.
    Lin J; Yu S; Wang R; Chen J
    J Int Med Res; 2020 Feb; 48(2):300060519897481. PubMed ID: 32046545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of rituximab to reduced-dose CHOP chemotherapy is feasible for elderly patients with diffuse large B-cell lymphoma.
    Shin HJ; Chung JS; Song MK; Kim SK; Choe S; Cho GJ
    Cancer Chemother Pharmacol; 2012 May; 69(5):1165-72. PubMed ID: 22215473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric Castleman disease presenting with fever.
    Smith C; Lee-Miller C; Dishop MK; Cost C; Wang M; Asturias EJ
    J Pediatr; 2014 Dec; 165(6):1261-5. PubMed ID: 25282064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease.
    Lurain K; Yarchoan R; Uldrick TS
    Hematol Oncol Clin North Am; 2018 Feb; 32(1):75-88. PubMed ID: 29157621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and treatment of 7 Chinese TAFRO syndromes from 96 de novo Castleman diseases: a 10-year retrospective study.
    Zhang Y; Suo SS; Yang HJ; Zhou XP; You LS; Yu WJ; Wang ZM; Jin J
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):357-365. PubMed ID: 31938902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese variant of multicentric castleman's disease associated with serositis and thrombocytopenia--a report of two cases: is TAFRO syndrome (Castleman- Kojima disease) a distinct clinicopathological entity?
    Masaki Y; Nakajima A; Iwao H; Kurose N; Sato T; Nakamura T; Miki M; Sakai T; Kawanami T; Sawaki T; Fujita Y; Tanaka M; Fukushima T; Okazaki T; Umehara H
    J Clin Exp Hematop; 2013; 53(1):79-85. PubMed ID: 23801138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report of six kidney disease-associated Castleman's disease cases.
    Sui Y; Zhao D
    Clin Nephrol; 2015 Dec; 84(6):344-52. PubMed ID: 26445003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Idiopathic multicentric Castleman disease with Sjögren's syndrome and secondary membranous nephropathy: a case report and review of the literature.
    Pan Y; Cui Z; Wang S; Zheng D; Deng Z; Tian X; Guo H; Bao W; Zhou S; Wang Y
    BMC Nephrol; 2020 Dec; 21(1):528. PubMed ID: 33276741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse Large B-cell Lymphoma during Corticosteroid Therapy for TAFRO Syndrome.
    Ohya E; Mizutani M; Sakaguchi H; Sekine T
    Intern Med; 2016; 55(19):2861-2867. PubMed ID: 27725549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study.
    Shipp MA; Neuberg D; Janicek M; Canellos GP; Shulman LN
    J Clin Oncol; 1995 Dec; 13(12):2916-23. PubMed ID: 8523055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor.
    Hernàndez DE; Hernàndez AE
    Eur J Cancer Care (Engl); 2006 Dec; 15(5):493-6. PubMed ID: 17177909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentric Castleman disease of hyaline vascular variant presenting with unusual systemic manifestations: a case report.
    Basnayake BMDB; Wazil AWM; Kannangara T; Ratnatunga NVI; Hewamana S; Ameer AM
    J Med Case Rep; 2017 May; 11(1):135. PubMed ID: 28501028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of age group on febrile neutropenia risk assessment and management in patients with diffuse large B-cell lymphoma treated with R-CHOP regimens.
    Lugtenburg P; Silvestre AS; Rossi FG; Noens L; Krall W; Bendall K; Szabo Z; Jaeger U
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):297-305. PubMed ID: 23040435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of R-CVP with R-CHOP for very elderly patients aged 80 or over with diffuse large B cell lymphoma.
    Arakaki H; Nakazato T; Osada Y; Ito C; Aisa Y; Mori T
    Ann Hematol; 2017 Jul; 96(7):1225-1226. PubMed ID: 28508175
    [No Abstract]   [Full Text] [Related]  

  • 17. A patient with Castleman's disease mimicking acute pancreatitis.
    Wu J; Lv L; Wang C
    Rev Esp Enferm Dig; 2017 Oct; 109(10):737-738. PubMed ID: 28929773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal positron emission tomography (PET) scan secondary to the use of hematopoietic growth factors.
    Johnston KL; Farnen JP; Manske BR; Go RS
    Haematologica; 2005 Dec; 90(12 Suppl):EIM03. PubMed ID: 16464762
    [No Abstract]   [Full Text] [Related]  

  • 19. Front-line immunochemotherapy for aggressive non-Hodgkin lymphoma using dose-dense rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone plus granulocyte-macrophage colony stimulating factor and pegfilgrastim as support.
    Cabanillas F; Cotto M; Liboy I; Rivera E; Pavia OA; Bruno M
    Leuk Lymphoma; 2012 Oct; 53(10):1929-33. PubMed ID: 22448918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and outcome of patients with HIV-negative multicentric Castleman's disease treated with combination chemotherapy: a report on 10 patients.
    Zhu SH; Yu YH; Zhang Y; Sun JJ; Han DL; Li J
    Med Oncol; 2013 Mar; 30(1):492. PubMed ID: 23400962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.